Clinical Research Directory
Browse clinical research sites, groups, and studies.
Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing
Sponsor: University Hospital, Strasbourg, France
Summary
This study focuses on children with Developmental and Epileptic Encephalopathy (DEE), a severe form of epilepsy that often has a genetic origin. Currently, standard diagnostic tools-known as short-read genome sequencing-fail to provide a diagnosis for over 50% of affected patients because they cannot detect certain complex DNA abnormalities. The purpose of this study is to evaluate the effectiveness of a newer, more advanced technology called Long-read Genome Sequencing (lrWGS). Unlike traditional methods, this technology analyzes very long fragments of DNA, allowing researchers to identify genetic errors that were previously "invisible." The study aims to answer whether Long-read Sequencing can successfully identify the genetic cause of epilepsy in patients who have already received a negative result from standard testing. By finding these missing answers, the research seeks to enable personalized medical treatments, improve genetic counseling for families, and advance our understanding of how these complex neurological conditions develop.
Official title: Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing - EEPILOG
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2026-06
Completion Date
2028-06
Last Updated
2026-02-09
Healthy Volunteers
No
Interventions
Long-read Whole Genome Sequencing (lrWGS)
Long-read Whole Genome Sequencing (lrWGS) using high-molecular-weight DNA previously extracted and banked during the patient's initial clinical workup.
Locations (4)
CHU Jean Minjoz
Besançon, France
American Memorial Hospital
Reims, France
Hôpitaux Universitaires de Strasbourg
Strasbourg, France
CHU de Nancy - hôpital d'enfant
Vandœuvre-lès-Nancy, France